[REGN] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 18.28%
YoY- -3.46%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 2,294,000 1,952,000 1,828,200 2,169,500 2,048,400 1,933,700 1,711,800 21.48%
PBT 998,300 918,900 668,600 889,800 768,500 224,700 546,100 49.34%
Tax 156,200 21,600 44,000 97,800 98,900 31,600 85,000 49.86%
NP 842,100 897,300 624,600 792,000 669,600 193,100 461,100 49.24%
Tax Rate -15.65% -2.35% -6.58% -10.99% -12.87% -14.06% -15.56% -
Total Cost 1,451,900 1,054,700 1,203,600 1,377,500 1,378,800 1,740,600 1,250,700 10.42%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 36.71 45.97 34.16 36.51 32.69 9.99 26.94 22.84%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS 7.98 8.19 5.69 7.25 6.12 1.77 4.23 52.50%
EPS Diluted 7.39 7.61 5.43 6.93 5.86 1.68 3.99 50.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.